4Front Ventures Corp. FFVWF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • USD

SharesGrow Score

19/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

4Front Ventures Corp. (FFVWF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 18/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

19/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

28/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — FFVWF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率2.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.14

每股账面价值$0.00

每股营收$0.15

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2014	$-0.48	$8.71K	$-182.62K	-2097.3%
2015	$-0.37	$0.00	$-140.33K	-
2016	$0.05	$2.01M	$-157K	-7.8%
2017	$-0.11	$3.83M	$-3.02M	-78.8%
2018	$-0.08	$4.06M	$-52.55M	-1295.7%
2019	$-0.43	$19.03M	$-182.01M	-956.3%
2020	$-0.09	$57.64M	$-47.05M	-81.6%
2021	$-0.06	$104.57M	$-38.31M	-36.6%
2022	$-0.07	$107.66M	$-46.9M	-43.6%
2023	$-0.14	$97.44M	$-91.65M	-94.1%